Pirfenidone
Last Updated: 09/19/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2512 publications
Comparative Clinical Outcomes of Nintedanib and Pirfenidone in Idiopathic Pulmonary Fibrosis: A Five-year Real-life Study.
Journal: Thoracic research and practice
Published: September 04, 2026
Patient-reported adverse events and management of antifibrotic therapy in IPF: A multicenter, cross-sectional real-world study.
Journal: Therapeutic advances in respiratory disease
Published: August 31, 2026
Chinese expert consensus on the diagnosis and treatment of pneumoconiosis complicated with tuberculosis
Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: August 05, 2026
Lung organoids as emerging models in idiopathic pulmonary fibrosis research: Current applications, challenges, and future directions.
Journal: Therapeutic advances in respiratory disease
Published: August 04, 2026
Towards ischemic tissue regeneration and protection: design of a drug-loaded multilayered cardiac patch with synergistic degradation and release.
Journal: Biomaterials science
Published: August 03, 2026
Maiwei Yangfei Decoction alleviates pulmonary fibrosis in mice by inhibiting cellular senescence via p53 signaling pathway
Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
Published: August 02, 2026
"Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial." G. Bermudo-Peloche, B. Del Rio, V. Vicens-Zygmunt, et al. Eur Respir J 2025; 65: 2402249.
Journal: The European respiratory journal
Published: July 30, 2026
Precision Modulation of the PDE4 Pathway: The Emerging Role of Nerandomilast in Pulmonary Fibrosis.
Journal: The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians
Published: July 23, 2026
Comparative analysis of drug therapy for fibrotic interstitial lung diseases based on results of phase 3 study
Journal: Pneumologie (Stuttgart, Germany)
Published: July 06, 2026
Tracking Dynamic Variations of Reactive Oxygen Species and Temperature during Ferroptosis-Induced Hepatic Stellate Cell Activation.
Journal: ACS nano
Published: June 17, 2026
Correction to "Tissue-Microenvironment-Responsive Self-Assembling Peptide Nanoshells Boost Pirfenidone Efficacy in the Treatment of Liver Fibrosis".
Journal: Advanced healthcare materials
Published: June 17, 2026
Toxicity management in thoracic chemoradioimmunotherapy: pirfenidone for low grade pneumonitis and lung fibrosis.
Journal: Chinese clinical oncology
Published: June 11, 2026
Last Updated: 09/19/2026